Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Company focused on broadening access to innovative solutions for people with type 1 and type 2 diabetes and designing high-touch customer care experiences MILPITAS, Calif.–(BUSINESS WIRE)–December 9, ...
Lifecore Biomedical, Inc. announced a new 10-year commercial manufacturing and supply agreement with one of its existing customers to support the development of a novel ophthalmic therapeutic. This ...
Elizabeth Holmberg brings extensive experience in capital formation, strategic partnerships, and scaling innovative ...
12d
Micron Biomedical Celebrates the Grand Opening of Its Commercial-Scale Manufacturing Site in Georgia
Micron Biomedical today announced the grand opening of its world-class manufacturing facility spanning more than 26,000 ...
Mr. DaFonseca Possesses Nearly 30 Years of Broad Drug Development Experience, including More than 15 Years Leading High Performing CDMO Sales Organizations Will Leverage Deep Pharma Services Expertise ...
HONG KONG, Mar 13, 2024 - (ACN Newswire) - Absolute Pure EnviroSci Limited ("APEL") Biomedical Technology Innovation and Translational Commercial Laboratory has officially opened at Hong Kong Science ...
CAMBRIDGE, Mass., Nov. 14, 2013 /PRNewswire/ -- Boston Biomedical, Inc. and Boston Biomedical Pharma Inc., collectively "Boston Biomedical", announced that it has appointed Patricia S. Andrews as ...
I’m not the type who has ever written reminders to myself on my hand arm or other less-obvious body part, but I know that’s still something people do, even in the age of smartphones. Maybe having the ...
MILPITAS, Calif.--(BUSINESS WIRE)--As it readies for FDA clearance of its first product and subsequent launch of its innovative program, Bigfoot Biomedical announced today it has established an ...
Lifecore Biomedical Signs Commercial Site Transfer Agreement with Leading Medical Aesthetics Company
CHASKA, Minn., March 23, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated injectables contract development and manufacturing organization (“CDMO”), ...
-- Agreement for the Commercial Manufacture of Established, Approved Aesthetic Product -- -- Third Commercial Site Transfer Agreement Win in Five Months -- -- Program Expected to Generate Commercial ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results